Eph receptors and ephrins in cancer: bidirectional signaling and beyond

(A) EPHA2/HRAS-Erk negative feedback loop. Activation of the HRAS-Erk pathway increases EPHA2 expression through MEK1 and decreases EPHRIN-A1 expression, although it is not known if this also occurs through MEK1,,. In turn, ephrin-dependent EPHA2 activation inhibits HRAS-Erk signaling and also downregulates EPHA2 levels by causing receptor internalization and degradation. (B) Positive and negative EPHB2/MAP kinase feedback loops. In a positive feedback loop, ephrin-B-dependent EPHB2 activation stimulates the HRAS-Erk pathway, and the increase in Mek and/or Erk activity in turn enables enhanced responsiveness of EPHB2 to ephrin-B stimulation through unknown mechanisms. However, in a different cellular context EPHB2 can also inhibit the HRAS-Erk pathway,, which may in turn reduce EPHB2 activation by ephrin. Although not shown in the figure, EPHRIN-B1 stimulation can also downregulate EphB2 levels by causing internalization/degradation. (C) EPHA2/Akt negative feedback loop. The Akt kinase (activated by growth factor receptors (GFR), Src family kinases or mutations in upstream proteins or Akt itself) phosphorylates serine 897 in the carboxy-terminal tail of EPHA2 leading to increased EPHA2-dependent cell migration and invasion. In turn, EPHRIN-A1-induced EPHA2 signaling inactivates Akt by causing its dephosphorylation at T308 and S473, thus decreasing EPHA2 phosphorylation at serine 897 and, consequently, cell migration and invasion. Other pathways downstream of EPHA2 can also inhibit migration and invasion. (D) EPHA2/E-CADHERIN positive feedback loop. E-CADHERIN expression increases EPHA2 expression, surface localization, interaction with EPHRIN-A1, and thus forward signaling, (Box 1). In turn, EPHA2 signaling enhances E-CADHERIN-mediated adhesion. Dotted lines indicate regulation of protein levels rather than activity.
Eph receptors and ephrins in cancer: bidirectional signaling and beyond

Publication

Eph receptors and ephrins in cancer: bidirectional signaling and beyond. () Elena B. Pasquale. Nat Rev Cancer. ;10(3):165-180. Figure: F2.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates EPHA2 EPHA2 ncbigene_symbol EPHA2 1969
Homo sapiens Primates EPHB2 EPHB2 ncbigene_symbol EPHB2 2048
Homo sapiens Primates P120RASGAP P120RASGAP ncbigene_synonym RASA1 5921
Homo sapiens Primates Akt AKT ncbigene_synonym AKT1 207
Homo sapiens Primates Akt AKT famplex_relations AKT2 208
Homo sapiens Primates Akt AKT famplex_relations AKT3 10000
Homo sapiens Primates HRAS HRAS ncbigene_symbol HRAS 3265
Homo sapiens Primates GFR GFR ncbigene_synonym RAPGEF5 9771
Homo sapiens Primates Src SRC ncbigene_symbol SRC 6714
Homo sapiens Primates Src SRC famplex_relations FGR 2268
Homo sapiens Primates Src SRC famplex_relations FYN 2534
Homo sapiens Primates Src SRC famplex_relations YES1 7525
Homo sapiens Primates Raf RAF ncbigene_synonym ZHX2 22882
Homo sapiens Primates Raf RAF famplex_relations ARAF 369
Homo sapiens Primates Raf RAF famplex_relations BRAF 673
Homo sapiens Primates Raf RAF famplex_relations RAF1 5894
Homo sapiens Primates MEK1 MEK1 ncbigene_synonym MAP2K1 5604
Homo sapiens Primates MEK2 MEK2 ncbigene_synonym MAP2K2 5605
Homo sapiens Primates Mek MEK ncbigene_synonym MAP2K7 5609
Homo sapiens Primates E-CADHERIN CDH1 ncbigene_symbol CDH1 999
Homo sapiens Primates E-CADHERIN CDH1 ncbigene_synonym FZR1 51343
Homo sapiens Primates Erk ERK ncbigene_synonym MAPK1 5594
Homo sapiens Primates Erk ERK famplex_relations MAPK3 5595

Chemical mentions

Word Match MeSH Name ChEBI
O serine Serine mesh:D012694 L-serine chebi:17115
threonine Threonine mesh:D013912 L-threonine chebi:16857
tyrosine Tyrosine mesh:D014443 L-tyrosine chebi:17895

Disease mentions

Word Match MeSH Name DOID
Cancer NA